Navigation Links
Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
Date:7/31/2008

- Conference Call Today at 5:00 p.m. Eastern Time -

SOUTH SAN FRANCISCO, Calif., July 31 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today reported on its corporate progress and financial results for the second quarter ended June 30, 2008.

"Our strategy and focus are to develop picoplatin as an oncology platform compound addressing multiple indications, combinations and formulations. Our accomplishments during the second quarter are consistent with this objective," said Jerry McMahon, Ph.D., chairman and CEO of Poniard. "We are on track to commercialize picoplatin for the treatment of small cell lung cancer (SCLC) in 2010. We presented data at the American Society of Clinical Oncology (ASCO) Annual Meeting in June, illustrating the platform potential of picoplatin in multiple solid tumor indications, including metastatic colorectal cancer (CRC), hormone refractory prostate cancer (HRPC) and ovarian cancer. Data from these trials could support future trials and may be of significant interest to potential partners. We are building a comprehensive strategy to direct our clinical development plan for further development of picoplatin in a wide range of tumor types."

Second Quarter and Recent Highlights

Picoplatin Clinical Development Program

-- Small Cell Lung Cancer: Presented final data in April from our Phase 2 trial of picoplatin in SCLC at the International Association for the Study of Lung Cancer and the European Society for Medical Oncology's 1st European Lung Cancer Conference. Final efficacy results confirmed previously announced interim results showing median overall survival in the picoplatin Phase 2 trial w
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , , DALLAS, Nov. 27 /PRNewswire-USNewswi... medical procedure only 25 years ago, solid organ ...eration thanks to the extraordinary men and women ... on Nov. 11. Leaders came together from medical ce...ersary of Baylor Regional Transplant Institute (BR...
(Date:11/27/2009)... , , NEUILLY-SUR-SEINE, France, Nov. 27... American professional cycling team dedicated to e... of cycling champions, announced today that it wil... of Transitions Optical as a new sponsor of the te...ufacturer of adaptive eyewear, offering the most a...
(Date:11/27/2009)... Walking and cycling plus low-emission vehicles m..., , FRIDAY, Nov. 27 (HealthDay News) -- E...ad of using cars would offer much greater public h... vehicles, U.K. researchers have found. , The s... of alternative urban land transport scenarios for...
(Date:11/27/2009)... , Voyant Health™ a... Michigan) has licensed its TraumaCad Enterprise o...tend workflow solution. , ... announced today that Spectrum Health (Grand Rapid... orthopedic templating solution and its TraumaCad ...
(Date:11/27/2009)... , Three new interactive ...t Williams & Wilkins expand health sciences le... Durham, NC (Vocus) Novembe...iams & Wilkins (LWW), a division of Wolters Kl...hree new anatomy education apps on the App Store. ...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...ficant and substantial, and calls for ...., July 29 Eric Svenson, PSEG,s,vice president of...efore,Congress about the implications of a recent ...resulted in dramatic reductions,in particulate mat...
... FDA needed regulatory authority,over tobacco prod...tement by Ron Davis, M.D., American Medical Associ...U.S. House of Representatives must take a critical...obacco products., "Given what we know about the d...
... Casa Saba,S.A.B. de C.V. (SAB) announces the pass.... Isaac Saba Raffoul, this past Sunday, July 27, 2...deeply sorry for the loss and,extend their most si...rd work and his commitment to both the company,and...
...0, millions of breast,cancer survivors, advocates,... glasses in a "Toast to the Cure.", This "Raise Y...one,affected by breast cancer to memorialize those...rters, and showing,conviction for the future -- an...
...ers at the 115th,Annual Convention of the American...ronic stress can intensify inflammation and increa...system infections, neurodegenerative,diseases, and...lems, job loss, poor,diet, and environmental pollu...
...ts stop drug-taking athletes from damaging sport b...genetic manipulation is a constant challenge, acco...e World,s leading experts on doping in sport. , ...st drugs in sport over the last 40 years. However,...
Other Medicine News:Health News:PSEG Supports Quick Congressional Action on Clean Air in Wake of Court's Rescinding of CAIR 2Health News:Video: A 'Toast to the Cure' Set for October 30 Breast Cancer Survivors 'Raise Your Glasses' 2Health News:New Research Shows Chronic Stress Worsens Neurodegenerative and Inflammatory Illnesses 2Health News:Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport 2Health News:Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport 3
(Date:11/25/2009)...., Nov. 25 American Sc...Company") is pleased to announce that they have op...t office in Shanghai, China. ,, ASR has been ab...tial gateway for the development and production of... children and adults to be distributed and sold gl...
(Date:11/25/2009)...FA, Switzerland, Nov. 25 From Nov...nnovative hearing solutions, presented the second ... focusing on the special needs of the older popula...rts in aging and audiology from around the world a... older people with hearing loss for an opportunity...
(Date:11/25/2009)... Calif., Nov. 25 AMPAC Fine Chemic...rporation (Nasdaq: APFC ) announced today that it...tainability Award at the Annual Statewide Environm...urers and Technology Association (CMTA), the Indus...ical Industry Council of California (CICC) held in...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3RIT scientist shines laser light on methane in pursuit of clean fuel 10490 1RIT scientist shines laser light on methane in pursuit of clean fuel 10490 2Biochemical on switch could solve protein purification challenge 10485 1Biochemical on switch could solve protein purification challenge 10485 2Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 1Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 2Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 3
...ontributing Editor , ,Celiac disease (CD) is ...testine that is triggered in genetically susceptib...ng grains wheat, rye, barley, and possibly oats. T...ion of both a T-cell and B-cell immune response, l...nd crypt hyperplasia, and is self-perpetuating wit...
...idge Healths large multi-site lab faced challenges...itation management challenges which were exacerba...he lab realized that better document control was e...enable their laboratorians to more efficiently acc...a variety of Quality Management software packages ...
Other Medicine Technology:Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3Choosing Lab Quality Management Software 2Choosing Lab Quality Management Software 3Choosing Lab Quality Management Software 4
QC OnCall
...an imaging agent that provides non-invasive, fast,...ive years of age or older with equivocal signs and... see clearly the "function" of the appendix rather...iagnosis. NeutroSpec attaches to the white blood c...
Fathom Steerable Guidewire
Urine Reagent Strips (URS9)
Medicine Products: